Eighty Steps a Minute Is Not Brisk: What the New Walking Study Actually Found

The walking research has spent fifteen years arguing about a single number. This week it quietly acquired a second one.

On Tuesday the British Journal of Sports Medicine published an analysis of 103,684 middle-aged adults from UK Biobank who, sometime between 2013 and 2015, agreed to wear an accelerometer on the wrist for seven consecutive days. The device counted their steps. It also recorded how quickly they took them, which is the part that turned out to matter. Roughly eight years later the researchers went back to see who was still alive.

The coverage that followed was generous to the tired reader: you may not need 10,000 steps if some of them are faster. Read the actual table and it reads less like permission and more like a correction. Pace did not replace volume. It rescued the people who had almost none of it.

What the study actually put on the table

The team — Le Wei, Matthew Ahmadi, Nicholas Koemel, Raaj Kishore Biswas, Borja del Pozo Cruz and Emmanuel Stamatakis — split the cohort two ways at once. First by daily volume, into four bands: under 5,000 steps, 5,000 to 7,500, 7,500 to 10,000, and above 10,000. Then by intensity, using a measure called peak-30 cadence: the average steps per minute across your thirty fastest minutes of the day, and they need not be consecutive minutes.

That second definition is more forgiving than it sounds. Nobody is asked to hold a pace from breakfast to bedtime. The metric goes looking for your best half hour and ignores the rest.

Over about eight years of follow-up, 1,697 of the 64,743 people in the all-cause analysis died, and 502 of the 70,075 in the cardiovascular analysis died of cardiovascular causes. Two results stand out. People taking fewer than 5,000 steps a day at 80 steps per minute or more had a mortality risk broadly comparable to people taking 5,000 to 7,500 steps at around 60 per minute — the two dials substituting for one another at the bottom of the range. And the lowest risk of all sat in the 7,500-to-10,000-step band, more or less regardless of pace.

So the trade is real, and it is local. If you already walk a reasonable amount, speed is not a shortcut you can take instead. If you walk very little, it is the cheapest thing available to you. The authors say as much: their interest is in people with genuine barriers to walking further.

Eighty steps a minute is not brisk

Here is the detail that almost nothing in the news cycle mentioned. Eighty steps a minute is not a brisk walk. It is below the accepted threshold for moderate intensity.

We know this because Catrine Tudor-Locke's CADENCE-Adults programme spent years putting people on treadmills to calibrate exactly that. In adults aged 21 to 40, moderate intensity arrives at about 100 steps per minute; vigorous at about 130; and above 100, each extra ten steps per minute buys roughly one more MET. The work was repeated in 41-to-60-year-olds and again in 61-to-85-year-olds, with the same landmark holding up.

Put the new study's numbers on that ruler and the shape of the finding changes. The pace that did the rescuing sits to the left of moderate. It is not power-walking. It is the difference between drifting past shop windows and walking like you have somewhere to be.

Figure — the cadence ruler

Where 80 steps a minute actually falls

A careful earlier study found that pace did not matter

This is the part a good newsjack owes you, because the literature is not unanimous and pretending otherwise is how wellness advice goes stale.

In 2020, Pedro Saint-Maurice and colleagues published a US cohort study in JAMA: 4,840 adults, mean age 57, wearing accelerometers, followed for around a decade. Volume came through emphatically — 8,000 steps a day versus 4,000 carried an adjusted hazard ratio of 0.49 for all-cause mortality. Intensity did not. Once total daily steps were accounted for, step intensity showed no significant association with mortality at all.

Two years later, del Pozo Cruz and colleagues ran the peak-30 measure through 78,500 UK Biobank participants and found the opposite: peak-30 cadence tracked with lower all-cause mortality beyond what total steps explained. Worth keeping the absolute scale in view, though. Comparing the top and bottom fifths of peak-30 cadence, the difference was about 8 extra deaths per 10,000 person-years.

So: two competent teams, two answers, different instruments. Volume is the older, sturdier, more replicated finding. Intensity is the newer, more interesting, less settled one. The grown-up position is to say that out loud rather than pick the study that makes a better headline.

Your tracker counts the thing that is easy to count

Notice what all of this implies about the number on your wrist. Cadence is not exotic data. It is computable from exactly the same raw accelerometer signal that produces your step count — the researchers derived peak-30 from the same seven days of wear. Almost no consumer device puts it in front of you.

The step total won the interface for the same reason the 10,000-step target won the culture: it is cheap to compute, trivially comparable between people, and it makes a satisfying ring close. Cadence asks a slightly harder question and offers no ring. So we all spent a decade optimising the metric that was easiest to display, which is not the same as the metric that was most informative. We wrote about the marketing origins of that target in how many steps, really, and about the general problem in what your wearable can and can't measure.

This is the whole argument for using numbers to correct fantasy rather than to replace experience. A step count told you that you moved. It never told you whether anything was asked of you.

The one number worth finding this week

Here is something you can do in twenty seconds, and it does not require buying anything.

On your next ordinary walk — to the station, around the block, wherever you already go — count your steps for twenty seconds and multiply by three. That is your cadence, in the units every study above uses. Most people are surprised, usually downwards.

If the number lands under about 80, the cheapest change available to you is not more walking. It is the same walking, slightly quicker, for one stretch of about half an hour. If you are already at 100 or above, you are at the moderate-intensity threshold, and volume is the lever with the stronger evidence behind it. Either way you now have two dials instead of one, which is the actual news.

Two honest caveats. Nobody randomised anyone here: these are people who chose their own pace, and the effect of choosing faster is not the same thing as the effect of being able to. And cadence is not a substitute for the rest of the day — prolonged sitting behaves like its own separate problem, which is why breaking it up and short bouts of everyday movement keep showing up independently.

Three studies, three claims — what each one can and cannot support

Wei et al., 2026 (Br J Sports Med). Can support: at low step volumes, a higher peak-30 cadence is associated with mortality risk similar to a higher volume at a slower pace. Cannot support: that speeding up causes the difference, or that fast walking substitutes for volume in already-active people.

Saint-Maurice et al., 2020 (JAMA). Can support: daily step volume is robustly associated with lower all-cause mortality. Cannot support: any independent role for intensity — in this cohort there wasn't one after adjustment.

del Pozo Cruz et al., 2022 (JAMA Internal Medicine). Can support: peak-30 cadence carries an association beyond total steps. Cannot support: a large absolute benefit — the top-to-bottom-fifth gap was about 8 deaths per 10,000 person-years.

What 1,697 deaths cannot tell you

The limitations are not a disclaimer here; they are half the story.

Seven days of wrist data, collected once, is standing in for eight years of behaviour. People who sustain 80 steps a minute for half an hour are, to some unknowable degree, simply people who can — the joints, the lungs and the mood all vote before the pace is chosen, and healthier people walk faster for reasons that have nothing to do with the walking. The authors excluded participants with existing cardiovascular disease or a cancer history, which helps and does not solve it.

And the counts are thinner than the sample size suggests. Under 1,700 deaths spread across four volume bands crossed with several cadence bands leaves some cells carrying very few events, which is exactly where confident-looking curves get wobbly. UK Biobank volunteers are also healthier, wealthier and less diverse than the UK as a whole.

None of that makes the study uninteresting. It makes it what a good observational study is: a well-aimed question, not an answer. If you want the measure with the least of this trouble attached to it, ordinary gait speed over four metres has been predicting survival for longer and with more consistency than any step target ever has.

The bottom line

The news this week is not that you can walk less. It is that the step count was only ever half of a two-dial instrument, and the other dial has been sitting unread inside your device the whole time. Around 7,500 to 10,000 steps a day still marked the lowest-risk band in this cohort, pace or no pace. Below that, walking a bit quicker for one half hour is the substitution the data supports — and the pace in question is 80 steps a minute, which is not brisk, not athletic, and not something anyone needs to buy a plan for.

Use the numbers to correct the fantasy. Then go for the walk. If you want the rest of the dials in one place, we keep them in the longevity protocol.